An Extension Protocol for Virologically Suppressed Subjects Who Successfully Completed PRO140_CD03 Study
Study sponsor: CytoDyn, Inc.
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2022-06-20Actual
Enrollment · participants56Actual
Source updated2025-10-30Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.